Pancreatic Cancer Research

ResearcherNational Center for Global Health and MedicineActive in the last 2 years

Yoichi Miyata

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5201-4477; OpenAlex author ID A5090505951. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: 2 papers

Papers 3

  1. Prognostic impact of dose reduced S-1 adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma: a retrospective multicenter study. Co-author DOI 10.1007/s10147-025-02742-0↗
  2. A novel scoring system for prognostic stratification of node-positive pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.gassur.2025.102187↗
  3. ASO Author Reflections: Proposal of Tumor Size as an Index for Biologic Factor of Resectability Status of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1245/s10434-023-14261-1↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yoji Kishi · 3 shared papers, 2023–2025 · strength 0.87
  2. Yoshifumi Beck · 2 shared papers, 2025 · strength 0.49
  3. Takahiro Einama · 2 shared papers, 2025 · strength 0.49
  4. Hideki Ueno · 1 shared paper, 2025 · strength 0.27
  5. Makoto Nishikawa · 1 shared paper, 2025 · strength 0.22
  6. Kazuki Kobayashi · 1 shared paper, 2025 · strength 0.22
  7. Akifumi Kimura · 1 shared paper, 2025 · strength 0.22

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.